Biostem U.S., Corporation, (OTCQB: HAIR) Scientific and Medical Board of Advisors Member Appointed Chief of Cardiothoracic Surgery. Biostem U.S., Corporation is a fully reporting Nevada corporation with offices in Clearwater, Florida. Biostem U.S. is a technology licensing company with proprietary technology centered on providing hair re-growth using human stem cells. The company also intends to train and license selected physicians to provide Regenerative Cellular Therapy treatments to assist the body's natural approach to healing tendons, ligaments, joints and muscle injuries by using the patient's own stem cells. Biostem U.S. is seeking to expand its operations worldwide through licensing of its proprietary technology and acquisition of existing stem cell related facilities. The company's goal is to operate in the international biotech market, focusing on the rapidly growing regenerative medicine field, using ethically sourced adult stem cells to improve the quality and longevity of life for all mankind. Biostem U.S., Corporation, (HAIR) announced yesterday that Dr. Tom Prendergast, a Biostem U.S., Corporation's Scientific and Medical Board of Advisors Member, was appointed Chief of Cardiothoracic Surgery at St. Francis Hospital.
Axcelis Technologies, Inc. (NASDAQ: ACLS) reached up 15.37% in morning trading to $.90 with 900K shares traded. Axcelis Technologies, Inc. is a world-leading provider of equipment and services to the semiconductor manufacturing industry. For over three decades, chipmakers from around the globe rely on Axcelis' tools and process expertise to form the transistors that power all electronics - from smartphones and laptops, cameras, personal music players and more. Axcelis Technologies, Inc. (ACLS) yesterday announced financial results for the quarter ended June 30, 2012. The Company reported second quarter revenue of $59.1 million, compared to $55.0 million for the first quarter of 2012. Net loss for the quarter was $471 thousand, or $0.00 per diluted share, which includes a $153 thousand or $0.00 per share restructuring charge. This compares to a net loss for the first quarter of 2012 of $10.0 million, or $0.09 per share, which includes a $2.9 million, or $0.03 per share restructuring charge. Cash and cash equivalents were $33.8 million at June 30, 2012.
Origin Agritech Limited (NASDAQ: SEED) reached up 11.54% in morning trading to $1.45 with 150K shares traded. Origin Agritech Limited is China's leading agricultural biotechnology company, specializing in crop seed breeding and genetic improvement, seed production, processing, distribution, and related technical services. Leading the development of Genetically Modified (GM) technology, Origin Agritech's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Over the years, Origin has established a robust GM seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits. Staffed by approximately 800 employees, Origin operates production and processing centers and breeding stations nationwide with sales centers located in key crop-planting regions. The Company also operates one winter nursery in Hainan province. Product lines are vertically integrated for corn, rice and canola seeds. Origin Agritech Limited (NASDAQ GS: SEED) today announced that the Company will report results for its fiscal year 2012 third quarter ended June 30, 2012, before the market opens on Tuesday, August 7, 2012.
For a detailed quote on any of the following companies, or to read the full news articles visit PennyTrader.com
About PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.
Disclosure: PennyTrader.com and affiliates have been compensated ten thousand dollars by a third party for HAIR promotional email services.
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to CLICK HERE
